Medical devices, healthcare technology and the business of care
510(k) clearance · K254289

Portable Oxygen Concentrator (OX-1A-E, OX-1B)

Oxytek Medical Technology Co., Ltd. · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK254289

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-23 for K254289, a traditional 510(k) submitted by Oxytek Medical Technology Co., Ltd. of Foshan, China, for the Portable Oxygen Concentrator models OX-1A-E and OX-1B. The device falls under classification name Generator, Oxygen, Portable, regulation number 868.5440, product code CAW, with anesthesiology as the regulation medical specialty and review panel. The application was received on 12/31/2025.

SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record lists Share Info (Guangzhou) Medical Consultant, Ltd. as correspondent, a traditional submission type, no third-party review, no combination product status, and no authorized predetermined change control plan. The public record does not include the predicate device, the summary of technological characteristics, or any performance testing, so the basis for the equivalence finding and the specific differences between the two models remain unknown.

The page was last updated 10/19/2026. No clinical, labeling or postmarket conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Sep 23, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254289
Regulatory pathway
510(k) premarket notification
Product code
CAW
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Generator, Oxygen, Portable.

Product code
CAW
FDA device class
2

FDA decision timeline

  1. K254289 received

    Application receipt date recorded by FDA.

  2. K254289 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Oxytek Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chencun Town, Shunde District, Foshan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records